1511, 2018
Considerations for Working with Research-Naive vs. Experienced Sites
When recruiting patients with hard-to-enroll indications, [...]
811, 2018
Why Aren’t There Any FDA-Approved Drugs to Treat NASH?
The liver does many important things [...]
211, 2018
10 Lessons On Success in Asia-PAC Trials from DIA 2018
Earlier this year, a few of [...]
3110, 2018
You’re Holding Your Eye Drops Wrong – What Makes Ophthalmology Trials so Challenging?
Last week, one of our resident [...]
2310, 2018
A More Complete Scope for Advances in Women’s Health
When people think about women’s health, [...]
1110, 2018
The Politics of Investigator-Initiated Trials
Many clinical trials are initiated by [...]
410, 2018
Six Things We Can Do Now to Advance Clinical Research in CKD
The CKD community has set some lofty goals for the coming years. There are hopes to enroll 30% of patients with CKD in a clinical trial by 2030. This is important to create a more substantial research base for CKD.
2809, 2018
The Tumultuous History of Women’s Involvement in Clinical Research
Inclusion of women in clinical research [...]
